Alcon stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 66 to 76.
IBD's unique rating tracks share price movement with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research reveals that the best stocks typically have an RS Rating north of 80 in the early stages of their moves. See if Alcon stock can continue to rebound and hit that benchmark.
Can You Really Time The Stock Market?
Is Alcon Stock A Buy?
Alcon stock is building a saucer without handle with a 101.10 buy point. See if the medical stock can break out in volume at least 40% above average.
Earnings growth fell last quarter from 23% to 3%, but revenue rose from 5% to 6%.
Alcon stock earns the No. 14 rank among its peers in the Medical-Products industry group. Boston Scientific, Axogen and Penumbra are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
